|
Market Cap (1-Jul) $77,044,616 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.073 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 5 January 2023, 12:24. The announcement is not marked as price sensitive, and is 4 page(s) in length and 22.12kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.218% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It is now ranked as the 278th most shorted stock on the ASX with 0.641% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Notification of cessation of securities - IPD | 5 January 2023, 12:24 |
| Update to Expected Release of NCCN Guidelines | 23 December 2022, 8:25 |
| Notice of General Meeting & Voting Form | 21 December 2022, 9:32 |
| Virtual Meeting Online Guide | 21 December 2022, 9:31 |
You must be logged in to post a reply.
ImpediMed 